Benjamin G. Bitler
University of Colorado Anschutz Medical Campus(US)
Publications by Year
Research Areas
PARP inhibition in cancer therapy, Epigenetics and DNA Methylation, Tryptophan and brain disorders, Cancer Immunotherapy and Biomarkers, Immune cells in cancer
Most-Cited Works
- → Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers(2015)669 cited
- → BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression(2016)425 cited
- → Suppression of Nucleotide Metabolism Underlies the Establishment and Maintenance of Oncogene-Induced Senescence(2013)290 cited
- → PARP inhibitors: Clinical utility and possibilities of overcoming resistance(2017)237 cited
- → ARID1A-mutated ovarian cancers depend on HDAC6 activity(2017)224 cited
- → Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy(2020)197 cited
- → BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian Cancer(2017)172 cited
- → HMGB2 orchestrates the chromatin landscape of senescence-associated secretory phenotype gene loci(2016)164 cited
- → BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer(2016)145 cited
- → Genetic variation, population structure, and phylogenetic relationships of Triatoma rubida and T. recurva (Hemiptera: Reduviidae: Triatominae) from the Sonoran Desert, insect vectors of the Chagas’ disease parasite Trypanosoma cruzi(2006)131 cited